St Louis, Missouri, United States In 2005 was created St. Louis Arch Angels, which is appeared as VC. The main office of represented VC is situated in the St Louis. The venture was found in North America in United States.
The overall number of key employees were 3.
Comparing to the other companies, this St. Louis Arch Angels performs on 26 percentage points less the average number of lead investments. The high activity for fund was in 2013. The usual things for fund are deals in the range of 1 - 5 millions dollars. The typical startup value when the investment from St. Louis Arch Angels is 1-5 millions dollars. The top amount of exits for fund were in 2017. The fund is constantly included in 2-6 deals per year.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the St. Louis Arch Angels, startups are often financed by Cultivation Capital, Capital Innovators, BioGenerator. The meaningful sponsors for the fund in investment in the same round are Billiken Angels Network, iSELECT FUND, The Yield Lab. In the next rounds fund is usually obtained by Missouri Technology Corporation, BioGenerator, Prolog Ventures.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. The fund has specific favorite in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. We can highlight the next thriving fund investment areas, such as Medical Device, Biotechnology. Among the various public portfolio startups of the fund, we may underline Appistry, ImmunoPhotonics, Euclises Pharmaceuticals
Related Funds
Funds with similar focus
| Fund Name | Location |
| Arab Bank | Amman, Amman, Jordan |
| Cybernaut Westlake Partners | - |
| Cystic Fibrosis Trust | England, London, United Kingdom |
| Elm Street Ventures | Connecticut, New Haven, United States |
| Emerging Longevity Ventures | - |
| F.I.T. Ventures | - |
| Florida Opportunity Fund | Florida, United States, Winter Park |
| Glad Products Company | California, Oakland, United States |
| Growin Partners | Japan, Tokyo |
| JFE Chemical Corporation | Japan, Tokyo |
| LEXUES | Japan, Okinawa Prefecture, Uruma |
| New Jersey Economic Development Authority | New Jersey, Trenton, United States |
| NS Investment | Seoul, Seoul-t'ukpyolsi, South Korea |
| Peak Capital | Amsterdam, Noord-Holland, The Netherlands |
| Sana Kliniken | Bayern, Germany, Ismaning |
| Stax Inc | Boston, Massachusetts, United States |
| Tablomonto Ventures | Netherlands, Noord-Holland, North Holland |
| Technology Venture Corporation | Canada, New Brunswick, Ontario |
| Vector Media Group | New York, New York, United States |
| Wayfinder | Stockholm, Stockholm County, Sweden |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Peptyde Bio | $1M | 15 Nov 2022 | St Louis, Missouri, United States | ||
Impetus Agriculture | $1M | 04 Jun 2021 | City of Saint Louis, Missouri, United States | ||
Sequoia Sciences | $72K | 27 Jul 2020 | City of Saint Louis, Missouri, United States | ||
Amplified Sciences | $1M | 24 Apr 2020 | Indiana, United States | ||
IDEATE Medical | $4M | 01 Jan 2019 | - | ||
CheckTheQ | 01 Dec 2018 | St Louis, Missouri, United States | |||
Lean Media | $500K | 28 Feb 2018 | City of Saint Louis, Missouri, United States | ||
Transactly | $1M | 31 Jan 2018 | O’Fallon, Missouri, United States | ||
Aptimmune | $6M | 23 Jan 2018 | City of Saint Louis, Missouri, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Peptyde Bio | $1M | 15 Nov 2022 | St Louis, Missouri, United States | ||
Impetus Agriculture | $1M | 04 Jun 2021 | City of Saint Louis, Missouri, United States | ||
Sequoia Sciences | $72K | 27 Jul 2020 | City of Saint Louis, Missouri, United States | ||
Amplified Sciences | $1M | 24 Apr 2020 | Indiana, United States | ||
IDEATE Medical | $4M | 01 Jan 2019 | - | ||
CheckTheQ | 01 Dec 2018 | St Louis, Missouri, United States | |||
Lean Media | $500K | 28 Feb 2018 | City of Saint Louis, Missouri, United States | ||
Transactly | $1M | 31 Jan 2018 | O’Fallon, Missouri, United States | ||
Aptimmune | $6M | 23 Jan 2018 | City of Saint Louis, Missouri, United States |
